← Back to Search

Blue Light Blocking for Heart Surgery Recovery

N/A
Recruiting
Led By Randy J Nelson, PhD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No history of diagnosed psychiatric disorders or organ failure
Both men and women undergoing elective (non-emergency) on-pump CABG surgery, AVR, MVR, CABG AVR, CABG MVR, or SAH
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post-surgery
Awards & highlights

Study Summary

This trial is testing whether filtering out blue light at nighttime reduces post-surgical inflammation and moderates cognitive decline, mood, and sleep alterations in patients undergoing heart surgery.

Who is the study for?
This trial is for men and women without psychiatric disorders or organ failure, who are scheduled for elective heart surgeries like CABG, AVR, MVR, or SAH. Participants should not have a history of cardiac surgery, clotting disorders, severe lung disease (COPD), acute infections, cognitive deficits like dementia, immune disorders or conditions that may require blood transfusion during/after surgery.Check my eligibility
What is being tested?
The study tests if wearing blue light-blocking goggles at night after certain heart surgeries can reduce inflammation and improve mood, sleep quality and prevent cognitive decline. It compares the effects with clear goggles to see if blocking blue light leads to better recovery outcomes.See study design
What are the potential side effects?
Since this intervention involves non-invasive blue light-blocking goggles there might be minimal side effects such as discomfort from wearing the goggles. However specific side effects are not detailed in the provided information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have no diagnosed psychiatric disorders or organ failure.
Select...
I am scheduled for a non-emergency heart surgery that involves a heart-lung machine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in baseline central executive cognitive function (Trail Making Test (part B))
Change in baseline cognitive function (WAIS-R)
Change in baseline mood (Hamilton Depression Scale)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blue-light blocking gogglesExperimental Treatment1 Intervention
Patients recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be given blue-light blocking goggles to wear at nighttime.
Group II: Clear gogglesPlacebo Group1 Intervention
Patients recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be given clear goggles to wear at nighttime.

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
178 Previous Clinical Trials
62,954 Total Patients Enrolled
Randy J Nelson, PhDPrincipal InvestigatorWest Virginia University

Media Library

Blue light-blocking goggles Clinical Trial Eligibility Overview. Trial Name: NCT04578249 — N/A
Circadian Rhythm Disorder Research Study Groups: Clear goggles, Blue-light blocking goggles
Circadian Rhythm Disorder Clinical Trial 2023: Blue light-blocking goggles Highlights & Side Effects. Trial Name: NCT04578249 — N/A
Blue light-blocking goggles 2023 Treatment Timeline for Medical Study. Trial Name: NCT04578249 — N/A
~16 spots leftby Mar 2025